Equities

MedCap AB (publ)

  • Add to watchlist
  • Add to portfolio
  • Add an alert

MedCap AB (publ)

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (SEK)511.00
  • Today's Change-33.00 / -6.07%
  • Shares traded49.69k
  • 1 Year change+27.11%
  • Beta0.6150
Data delayed at least 15 minutes, as of Feb 09 2026 17:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

MedCap AB (publ) is a Sweden-based private equity company engaged in investments in and development of companies active primarily within the medical equipment sector. The Company reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.

  • Revenue in SEK (TTM)1.99bn
  • Net income in SEK196.90m
  • Incorporated2001
  • Employees592.00
  • Location
    MedCap AB (publ)Engelbrektsgatan 9-1STOCKHOLM 114 32SwedenSWE
  • Phone+46 8347110
  • Websitehttps://www.medcap.se/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
eQ Oyj628.13m230.25m4.90bn116.0021.766.6620.247.800.510.511.391.670.6445--109.39507,836.2023.6330.5826.9636.6198.7399.1536.6643.66----0.0398104.26-11.400.5821-21.20-2.58-22.85-5.77
Svolder AB464.80m440.30m5.03bn6.0012.000.9387--10.834.314.314.5555.020.0831--30.9977,466,660.007.879.148.009.1693.2797.7094.7395.04----0.0023.21-96.45-46.27-99.02-58.40--26.76
Spiltan Investment AB118.54m-264.51m5.65bn11.00------47.63-8.80-8.803.98--------10,776,090.00--2.01--2.03-----223.15249.50--0.2501--32.1935.939.57-1,834.99----31.95
Investment Oresund AB897.90m859.50m5.76bn6.006.711.09--6.4218.9118.9119.75116.240.1775----149,650,000.0016.994.2117.094.24----95.7389.64----0.0091142.17103.10--102.96----4.28
Creades publ AB1.28bn1.21bn6.46bn8.007.760.844--5.058.938.939.4182.170.1186----159,750,000.0011.256.1911.376.27----94.9196.84----0.000721.991.51-20.430.9151-19.76--2.71
MedCap AB (publ)1.99bn196.90m8.20bn592.0041.165.8224.834.1213.2213.22133.8193.390.91032.926.343,581,295.009.079.8011.0412.5658.0850.449.9710.621.6320.480.26470.0013.8219.0020.4430.3116.92--
Ratos AB25.03bn905.00m9.65bn12.32k14.560.85743.340.38572.7310.9875.9046.370.77618.795.802,031,580.003.723.275.264.9139.7033.354.793.810.950219.150.314754.06-4.818.58-79.56-10.1819.0515.74
Data as of Feb 09 2026. Currency figures normalised to MedCap AB (publ)'s reporting currency: Swedish Krona SEK

Institutional shareholders

41.08%Per cent of shares held by top holders
HolderShares% Held
Lannebo Kapitalf�rvaltning AB (Sweden)as of 30 Nov 20251.34m8.94%
Swedbank Robur Fonder ABas of 30 Dec 20251.20m7.99%
Spiltan Fonder ABas of 31 Dec 2024703.62k4.68%
Andra AP-fondenas of 31 Dec 2024613.02k4.08%
Nordea Investment Management ABas of 31 Oct 2025588.54k3.91%
Handelsbanken Fonder ABas of 31 Jan 2026411.66k2.74%
ODIN Forvaltning AS (Sweden)as of 28 Nov 2025379.00k2.52%
Alcur Fonder ABas of 31 Dec 2024343.83k2.29%
Danske Bank A/S (Investment Management Sweden)as of 30 Jun 2025327.00k2.17%
L�nsf�rs�kringar Fondf�rvaltning ABas of 31 Dec 2025267.69k1.78%
More ▼
Data from 30 Jun 2025 - 07 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.